The Sensor Line Combo (SLC) Study

This study explores the performance of an  insulin pump infusion line with a combined  CGM sensor.

The SLC study is a four day study of a
combined insulin cannula and glucose
sensor delivering Insulin in people
who live with Type 1 Diabetes

The SLC Study

The SLC Study aims to evaluate the accuracy of an experimental
CGM measuring glucose continuously in the immediate vicinity
of subcutaneous insulin delivery.

This study explores the performance of an  insulin pump infusion line with a combined  CGM sensor.

Taking place over 14 days, participants undergo 2 separate meal
tests of between 6-8 hours each as well as training, screening
and end of study visits. The device is inserted at the beginning
of the first meal test.

Become a participant!

Would you like to be a part of advancing care for diabetes?
We are looking for Individuals living with Type 1 Diabetes, aged between 21-75 to be a part of this trial.

If you are:

Living with Type 1 Diabetes
Aged Between 21 and 75
With HbA1c readings between 5.8% and 10%
Familiar with CGM technology
Then you may be perfect for this study!

Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be participant in this important area of research.

Get involved

Please contact the Research Group Leader to discuss your options.